Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan
Objective: The calcium channel blockers, such as flunarizine and cinnarizine, and rarely selective serotonin reuptake inhibitors and lithium can produce parkinsonism and tardive syndromes. Background:…Effect of exercise on neurodegenerative parkinsonism unmasked by dopamine blocking drugs (DRBD)
Objective: To test whether aerobic walking influences clinical status, biochemical and radiologic markers associated with degenerative parkinsonism unmasked by DRBD. Background: Failed trials of putative…Parkinson’s Disease Risk in Breast Cancer
Objective: Case report of two patients who developed symptoms of Parkinson’s disease after treatment with chemotherapy and radiation for breast cancer and to review the…Rotenone model of Parkinson’s disease: The dosing options in mice revisited
Objective: In the present study we have used various dosing protocols to induce the PD-like symptoms with the administration of rotenone in mice. Background: Parkinson's…Diagnostic Impact of Movement Disorders Subspecialty Consultations at a VA Hospital
Objective: Review the impact of subspecialty care on diagnosis patterns of patients with parkinsonism at the Jesse Brown VA (JBVA), a VA Consortium center. Background:…Salivary Alpha-Synuclein a new tool for the diagnosis of Parkinson’s disease?
Objective: The aim of the PARKSYN study was to test the utility of salivary alpha-synuclein (a-syn) concentration in the differential diagnosis between Parkinson's disease (PD)…Utility of DaTscan Imaging in Differentiating Drug Induced Parkinsonism from IPD and Other Forms of Parkinsonism
Objective: To determine clinical correlates which differentiate drug induced Parkinsonism (DIP) from IPD and other forms of Parkinsonism using DaT-SPECT imaging. Background: DaT-SPECT imaging is…Is Hypertension and Certain Anti Hypertensive Agents Increase The Risk of Parkinson Disease?
Objective: The aim of this study is measure the risk of PD related to hypertension and certain use of anti hypertensive treatment. Background: Cardiovascular risk…Transcranial sonography in the prognosis of drug-induced parkinsonism
Objective: We investigated the substantia nigra (SN) echogenicity in drug-induced parkinsonism (DIP), Parkinson's disease (PD), and healthy controls. A subgroup analysis of DIP by clinical…Prevalence of Parkinson’s disease and Drug-induced Parkinsonism from National Health Insurance Service Claims Data (NHISCD)
Objective: To evaluate the prevalence and characteristics of of drug induced parkinsonism Background: Drug induced parkinsonism (DIP) is a clinically important disease because it can…
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »